Tim Butler
Principal Scientist,
Quotient Therapeutics
Tim Butler is a member of the Genomic Sciences team at Quotient Therapeutics, where his work focuses on applying insights from somatic genomics to drug discovery, with particular emphasis on I&I and metabolic diseases. He contributes to efforts to combine sequencing, imagining, and spatial insights to uncover disease-relevant biology, identify promising therapeutic targets, and translate human genomic data into new treatment opportunities.
Sessions
-
Drug Target Discovery through Somatic Genomics28-Jan-2027Multi-Omics Stage